JPWO2021032855A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021032855A5 JPWO2021032855A5 JP2022510803A JP2022510803A JPWO2021032855A5 JP WO2021032855 A5 JPWO2021032855 A5 JP WO2021032855A5 JP 2022510803 A JP2022510803 A JP 2022510803A JP 2022510803 A JP2022510803 A JP 2022510803A JP WO2021032855 A5 JPWO2021032855 A5 JP WO2021032855A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- induction medium
- mesoderm
- population
- differentiation factors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1911955.1A GB201911955D0 (en) | 2019-08-20 | 2019-08-20 | Culture medium for haematopoietic induction |
| GB1911955.1 | 2019-08-20 | ||
| GBGB2012306.3A GB202012306D0 (en) | 2020-08-07 | 2020-08-07 | Culture medium for haematopoietic induction |
| GB2012306.3 | 2020-08-07 | ||
| PCT/EP2020/073407 WO2021032855A1 (en) | 2019-08-20 | 2020-08-20 | Culture medium for haematopoietic induction |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022545415A JP2022545415A (ja) | 2022-10-27 |
| JP2022545415A5 JP2022545415A5 (https=) | 2023-08-18 |
| JPWO2021032855A5 true JPWO2021032855A5 (https=) | 2023-08-18 |
Family
ID=72234836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510803A Pending JP2022545415A (ja) | 2019-08-20 | 2020-08-20 | 造血誘導用の培養培地 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220275335A1 (https=) |
| EP (1) | EP4017969A1 (https=) |
| JP (1) | JP2022545415A (https=) |
| KR (1) | KR20220047375A (https=) |
| CN (1) | CN114341349A (https=) |
| AU (1) | AU2020333918A1 (https=) |
| BR (1) | BR112022003083A2 (https=) |
| CA (1) | CA3150037A1 (https=) |
| IL (1) | IL290602A (https=) |
| MX (1) | MX2022001961A (https=) |
| WO (1) | WO2021032855A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201911953D0 (en) * | 2019-08-20 | 2019-10-02 | Adaptimmune Ltd | T cell production fram RAG inacivated iPSCs |
| US11591381B2 (en) | 2020-11-30 | 2023-02-28 | Crispr Therapeutics Ag | Gene-edited natural killer cells |
| WO2022144632A1 (en) | 2020-12-30 | 2022-07-07 | Crispr Therapeutics Ag | Compositions and methods for differentiating stem cells into nk cells |
| GB202102297D0 (en) * | 2021-02-18 | 2021-04-07 | Adaptimmune Ltd | Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells |
| WO2022241558A1 (en) * | 2021-05-18 | 2022-11-24 | The University Of British Columbia | A method for producing blood progenitor and progenitor t cells, resulting cells and methods and uses thereof |
| GB202205572D0 (en) | 2022-04-14 | 2022-06-01 | Adaptimmune Ltd | Engineered T cells |
| GB202208545D0 (en) | 2022-06-10 | 2022-07-27 | Adaptimmune Ltd | Production of immune cells |
| WO2024050534A2 (en) * | 2022-09-01 | 2024-03-07 | Regents Of The University Of Minnesota | In vitro generated hematopoietic stem progenitor cells and t cells and methods of making and using the same |
| KR102566680B1 (ko) * | 2022-09-28 | 2023-08-14 | (주)포에버엔케이 | 면역세포 및 자연살해세포 배양을 위한 신규한 이중배양 제조방법 및 이의 용도 |
| WO2024107010A1 (ko) * | 2022-11-17 | 2024-05-23 | 주식회사 씨티셀즈 | 미분화 줄기세포로부터 자연 살해 세포로의 분화 방법 및 이의 용도 |
| CN118360247A (zh) * | 2023-01-19 | 2024-07-19 | 中国科学院动物研究所 | 一种iSCLP细胞及其制备方法和应用 |
| GB202318950D0 (en) | 2023-12-12 | 2024-01-24 | Adaptimmune Ltd | Production of immune cells |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6677631B2 (ja) * | 2013-03-13 | 2020-04-08 | ウイスコンシン アラムナイ リサーチ ファウンデーシヨンＷｉｓｃｏｎｓｉｎ Ａｌｕｍｎｉ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | 定義された条件下におけるヒト多能性幹細胞の造血内皮分化のための方法及び材料 |
| WO2015199127A1 (ja) * | 2014-06-24 | 2015-12-30 | 国立大学法人京都大学 | 中胚葉細胞および造血細胞の製造方法 |
| AU2016211671B2 (en) * | 2015-01-26 | 2022-05-26 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| CN108431211B (zh) * | 2015-10-20 | 2026-03-24 | 富士胶片细胞动力公司 | 通过遗传编程的多谱系造血前体细胞产生 |
| CA3003152A1 (en) * | 2015-11-04 | 2017-05-11 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| WO2017100403A1 (en) * | 2015-12-08 | 2017-06-15 | Regents Of The University Of Minnesota | Human t cell derived from t cell-derived induced pluripotent stem cell and methods of making and using |
| US11141471B2 (en) * | 2016-04-25 | 2021-10-12 | Regen BioPharma, Inc. | Universal donor checkpoint inhibitor silenced/gene edited cord blood killer cells |
| WO2017193177A1 (en) * | 2016-05-13 | 2017-11-16 | Murdoch Childrens Research Institute | Haematopoietic stem/progenitor cells |
| CN110997904B (zh) * | 2017-03-21 | 2024-11-26 | 法国血液机构 | 改进造血移植物的方法 |
| SG11202006731VA (en) * | 2018-01-18 | 2020-08-28 | Agency Science Tech & Res | Method for differentiation of human pluripotent stem cell lines in suspension culture |
| GB201911953D0 (en) * | 2019-08-20 | 2019-10-02 | Adaptimmune Ltd | T cell production fram RAG inacivated iPSCs |
-
2020
- 2020-08-20 AU AU2020333918A patent/AU2020333918A1/en not_active Abandoned
- 2020-08-20 CA CA3150037A patent/CA3150037A1/en active Pending
- 2020-08-20 MX MX2022001961A patent/MX2022001961A/es unknown
- 2020-08-20 KR KR1020227009201A patent/KR20220047375A/ko active Pending
- 2020-08-20 BR BR112022003083A patent/BR112022003083A2/pt unknown
- 2020-08-20 EP EP20761198.9A patent/EP4017969A1/en not_active Withdrawn
- 2020-08-20 US US17/630,880 patent/US20220275335A1/en not_active Abandoned
- 2020-08-20 CN CN202080059143.3A patent/CN114341349A/zh active Pending
- 2020-08-20 WO PCT/EP2020/073407 patent/WO2021032855A1/en not_active Ceased
- 2020-08-20 JP JP2022510803A patent/JP2022545415A/ja active Pending
-
2022
- 2022-02-14 IL IL290602A patent/IL290602A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12606798B2 (en) | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions | |
| JP7212615B2 (ja) | 多能性幹細胞からｈｌａホモ接合免疫細胞への指向分化方法 | |
| JPWO2021032851A5 (https=) | ||
| JP2019103521A (ja) | 造血細胞分化を誘導するための方法および組成物 | |
| JPWO2021032855A5 (https=) | ||
| Weisel et al. | Stromal cell lines from the aorta-gonado-mesonephros region are potent supporters of murine and human hematopoiesis | |
| IL305018A (en) | Methods of producing haemogenic endothelial cells from pluripotent stem cells | |
| CN110997904B (zh) | 改进造血移植物的方法 | |
| Zhu et al. | Thymopentin enhances the generation of T-cell lineage derived from human embryonic stem cells in vitro | |
| Galić et al. | Generation of T lineage cells from human embryonic stem cells in a feeder free system | |
| CN103834613A (zh) | 制备多能心血管前体细胞及维持其心血管分化能力的方法 | |
| CN116376822A (zh) | 利用人多潜能干细胞体外制备t淋巴细胞 | |
| Guo et al. | Generation and clinical potential of functional T lymphocytes from gene-edited pluripotent stem cells | |
| Zandstra et al. | Cellular determinants affecting the rate of cytokine in cultures of human hematopoietic cells | |
| WO2025255886A1 (zh) | 一种诱导性nk细胞及其制备方法和应用 | |
| JPWO2021032852A5 (https=) | ||
| CN115087732B (zh) | 来自人T细胞来源的iPS细胞的细胞毒性T细胞 | |
| RU2022107099A (ru) | Культуральная среда для гемопоэтической индукции | |
| JPWO2022175401A5 (https=) | ||
| Hematti et al. | Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair | |
| CN101368180A (zh) | 一类能将间充质干细胞分化为造血细胞的小rna分子及其作用靶点 | |
| Kawai et al. | Feeder-free generation of CD4 single-positive helper T cells from human iPSCs via stage-specific modulation of Notch and TCR Signaling | |
| WO2023233339A1 (en) | Compositions and methods for differentiating stem cells into nk cells | |
| CN117264887A (zh) | 一种从hiPSCs获得hIL-12分泌型巨噬细胞的方法及应用 | |
| Ren et al. | Apoptosis inhibition enhances induced pluripotent stem cell generation during T cell reprogramming |